Labo Euromedis (XPAR:ALEMG) Debt-to-Equity : 0.00 (As of Jun. 2024)

Labo Euromedis Debt-to-Equity Chart

Labo Euromedis Annual Data
	Trend	Jul13	Jul14	Jul15	Jul16	Jul17	Dec19	Dec20	Dec21	Dec22	Dec23
Debt-to-Equity		Get a 7-Day Free Trial					1.25	0.46	0.38	0.37	0.44

Labo Euromedis Semi-Annual Data
	Jan14	Jul14	Jan15	Jul15	Jan16	Jul16	Jan17	Jul17	Jan18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Debt-to-Equity	Get a 7-Day Free Trial															0.40	0.37	0.41	0.44	-

Competitive Comparison of Labo Euromedis's Debt-to-Equity

For the Medical Distribution subindustry, Labo Euromedis's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Labo Euromedis's Debt-to-Equity Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Labo Euromedis's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Labo Euromedis's Debt-to-Equity falls into.

Labo Euromedis Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Labo Euromedis's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Labo Euromedis's Debt to Equity Ratio for the quarter that ended in Jun. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Labo Euromedis  (XPAR:ALEMG) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Labo Euromedis Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Labo Euromedis's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Labo Euromedis Business Description